To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: pilot study using dynamic contrast-enhanced Doppler ultrasound (Q80242426)

From Wikidata
Jump to navigation Jump to search
scientific article published on 11 September 2006
edit
Language Label Description Also known as
English
To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: pilot study using dynamic contrast-enhanced Doppler ultrasound
scientific article published on 11 September 2006

    Statements

    title
    To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: pilot study using dynamic contrast-enhanced Doppler ultrasound (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    16965911
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16965911%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    30 December 2019

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q80242426&oldid=1812241127"